Get the Stockscreener App
7.26
0.14%
0.010
After Hours:
7.20
-0.06
-0.83%
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc stock is traded at $7.26, with a volume of 3.07M.
It is up +0.14% in the last 24 hours and up +3.71% over the past month.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
See More
Previous Close:
$7.25
Open:
$7.19
24h Volume:
3.07M
Relative Volume:
1.27
Market Cap:
$2.69B
Revenue:
$9.47B
Net Income/Loss:
$-178.00M
P/E Ratio:
-15.12
EPS:
-0.48
Net Cash Flow:
$1.01B
1W Performance:
-1.22%
1M Performance:
+3.71%
6M Performance:
+6.92%
1Y Performance:
+15.24%
1-Day Range:
$7.11
$7.305
1-Week Range:
$7.11
$7.365
52-Week Range:
$4.25
$9.85
Bausch Health Companies Inc Stock (BHC) Company Profile
Name
Bausch Health Companies Inc
Sector
Phone
514-744-6792
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
7.26 | 2.64B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-24 | Downgrade | Piper Sandler | Neutral → Underweight |
| Jul-10-24 | Initiated | Raymond James | Mkt Perform |
| Sep-20-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jul-29-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-29-22 | Downgrade | Truist | Buy → Hold |
| Jul-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-13-22 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-17-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-22-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-17-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-24-20 | Initiated | Citigroup | Buy |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-22-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-12-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-02-19 | Initiated | Goldman | Neutral |
| Oct-25-19 | Initiated | Cowen | Outperform |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| Aug-15-19 | Upgrade | TD Securities | Hold → Buy |
| Jul-19-19 | Initiated | Wolfe Research | Outperform |
| Jun-11-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Jan-02-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Nov-05-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-18 | Upgrade | Piper Jaffray | Underweight → Neutral |
View All
Bausch Health Companies Inc Stock (BHC) Latest News
DURECT Acquired by Bausch Health Companies Inc. - orrick.com
These 4 Measures Indicate That Bausch Health Companies (NYSE:BHC) Is Using Debt Extensively - 富途牛牛
Bausch Health: Repricing Continues As Deleveraging Gains Traction (NYSE:BHC) - Seeking Alpha
Bausch Health Completes US$63 Million Durect Acquisition, Adds Breakthrough Hepatitis Therapy to Pipeline - MarketScreener
Bausch Health Companies Acquires Durect Corporation - Contract Pharma
Bausch Health completes acquisition of Durect Corporation, expanding late-stage liver disease portfolio - MarketScreener
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio - ACCESS Newswire
Bausch Health Brief: Says Completed Acquisition Of DURECT Corporation, Expanding Late-Stage Liver Disease Portfolio - MarketScreener
$350M Milestone Deal: Bausch Health Acquires DURECT's Breakthrough Liver Disease Treatment Pipeline - Stock Titan
Royal Bank of Canada Reduces Stake in Bausch Health Cos Inc. $BHC - MarketBeat
Questex’s Fierce Pharma Announces the 2025 Fierce Pharma Marketing Awards Winners - GlobeNewswire Inc.
Bausch Health Cos Inc. $BHC Shares Purchased by Cubist Systematic Strategies LLC - MarketBeat
Psoriasis Market: Epidemiology, Therapies, and Companies, - openPR.com
Hyperopia Market Overview: Epidemiology, Emerging Therapies, and Key Players | Featuring Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Compa - Barchart.com
Psoriasis Market: Epidemiology, Therapies, and Companies, DelveInsight | Featuring Amgen, Janssen, AbbVie, Novartis, AstraZeneca, Bausch Health, Eli Lilly, Sun Pharmaceutical, Janssen Biotech, UCB Inc - Barchart.com
Trexquant Investment LP Raises Stock Holdings in Bausch Health Cos Inc. $BHC - MarketBeat
North America Intraocular Lens Market Forecast and Company - GlobeNewswire
Trend Report: What drives Bausch Health Companies Inc.’s stock priceJuly 2025 PreEarnings & Growth Oriented Trade Recommendations - Lancaster City Council
Insider Trends: Does Bausch Health Companies Inc. have a sustainable dividendLong Setup & Verified Momentum Watchlists - Lancaster City Council
Bausch Health to acquire liver drug developer Durect for $1.75 per share - MSN
Bausch Health EVP Carson Seana sells shares worth $97k By Investing.com - Investing.com Canada
Bausch Health EVP Carson Seana sells shares worth $97k - Investing.com
What is Bausch Health Companies Inc.’s valuation compared to sectorFed Meeting & Verified Trade Idea Suggestions - beatles.ru
What’s the MACD signal for Bausch Health Companies Inc.July 2025 Rallies & Accurate Technical Buy Alerts - beatles.ru
Paulson increases ownership of Bausch Health common shares - MSN
Bausch Health Cos Inc. $BHC Stock Holdings Lowered by Biglari Capital CORP. - MarketBeat
Will Bausch Health Companies Inc. see short term momentumTrade Risk Report & Community Verified Swing Trade Signals - Newser
Quantitative breakdown of Bausch Health Companies Inc. recent moveEarnings Summary Report & Risk Managed Investment Signals - Newser
Is it time to cut losses on Bausch Health Companies Inc.Gap Down & Entry and Exit Point Strategies - Newser
Will Bausch Health Companies Inc. stock recover after recent drop2025 Volatility Report & Low Drawdown Momentum Trade Ideas - Newser
Is Bausch Health Companies Inc. stock a value trap2025 Dividend Review & Daily Oversold Bounce Ideas - خودرو بانک
What chart patterns are forming on Bausch Health Companies Inc.2025 Big Picture & Fast Entry Momentum Alerts - خودرو بانک
Will Bausch Health Companies Inc. outperform its industry peersJuly 2025 Analyst Calls & Weekly High Conviction Ideas - خودرو بانک
Is Bausch Health Companies Inc. stock a good dividend stock2025 Market Sentiment & Stepwise Trade Signal Guides - خودرو بانک
Quarry LP Takes Position in Bausch Health Cos Inc. $BHC - MarketBeat
Bausch Health’s Thermage technology surpasses 5 million treatments By Investing.com - Investing.com Nigeria
Can Bausch Health Companies Inc. generate free cash flowWeekly Earnings Recap & Capital Efficiency Focused Strategies - خودرو بانک
What does recent volatility data suggest for Bausch Health Companies Inc.July 2025 Intraday Action & Low Drawdown Investment Strategies - Newser
Will Bausch Health Companies Inc. continue its uptrendJuly 2025 Rallies & Low Drawdown Trading Strategies - Newser
Is Bausch Health Companies Inc. stock entering bullish territoryMarket Trend Report & Free Real-Time Volume Trigger Notifications - Newser
Bausch Health’s Thermage technology surpasses 5 million treatments - Investing.com
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System - Yahoo Finance
Does Bausch Health Companies Inc. show high probability of reboundTrade Risk Summary & Weekly High Potential Stock Alerts - Newser
Volume Profile Shows Strong Base for Bausch Health Companies Inc.Weekly Market Summary & Momentum Based Trading Signals - beatles.ru
Nuveen LLC Acquires Shares of 227,230 Bausch Health Cos Inc. $BHC - MarketBeat
Is Bausch Health Companies Inc. stock reversal real or fakeWeekly Volume Report & Safe Entry Point Alerts - Newser
Is Bausch Health Companies Inc. building a consolidation baseChart Signals & Reliable Price Action Trade Plans - Newser
Is Bausch Health Companies Inc. exposed to political risk2025 Retail Activity & Consistent Growth Equity Picks - خودرو بانک
Will Bausch Health Companies Inc. bounce back from current supportEarnings Recap Summary & AI Enhanced Execution Alerts - Newser
Bausch Health Companies Inc. Options Begin Trading for October 24th Expiration - AInvest
What high frequency data says about Bausch Health Companies Inc.Portfolio Risk Report & Weekly Watchlist of Top Performers - Newser
Bausch Health Companies Inc Stock (BHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):